You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study

Article metrics

Article menu

Download PDFPDF

Oral Plenary
Plenary I
IGCS20_1255
2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study
Free

 

Online download statistics by month:

Online download statistics by month: November 2020 to October 2024

AbstractFullPdf
Nov 202031024
Dec 20205708
Jan 20211807
Feb 2021704
Mar 20212208
Apr 202150014
May 20211108
Jun 20212020
Jul 2021105
Aug 20213011
Sep 20211014
Oct 202151024
Nov 2021104025
Dec 202159016
Jan 20225307
Feb 202280012
Mar 202299019
Apr 202299016
May 2022140025
Jun 2022166025
Jul 2022139010
Aug 2022170021
Sep 2022112020
Oct 202211208
Nov 202211008
Dec 202210607
Jan 202314006
Feb 202324106
Mar 2023139018
Apr 2023143023
May 20236205
Jun 20237809
Jul 202389018
Aug 2023140012
Sep 202394014
Oct 2023163013
Nov 202397014
Dec 20238204
Jan 20243605
Feb 20246605
Mar 202464026
Apr 2024117018
May 202489020
Jun 20247803
Jul 2024198012
Aug 20245803
Sep 20244405
Oct 20241101
Total40320606